Overexpression of the oxygen sensors PHD-1, PHD-2, PHD-3, and FIH Is associated with tumor aggressiveness in pancreatic endocrine tumors - PubMed (original) (raw)
Overexpression of the oxygen sensors PHD-1, PHD-2, PHD-3, and FIH Is associated with tumor aggressiveness in pancreatic endocrine tumors
Anne Couvelard et al. Clin Cancer Res. 2008.
Abstract
Purpose: Tumor hypoxia is associated with poor prognosis and resistance to treatment. Our aim was to assess the expression of proteins that act as cellular oxygen sensors, directly regulating the hypoxia inducible factor (HIF) pathway, i.e., prolyl hydroxylase domain proteins (PHD)-1, PHD-2, PHD-3, and FIH in pancreatic endocrine tumors (PET).
Experimental design: Immunohistochemical expression of these markers was examined in 109 PET included in tissue microarrays and representing various stages of tumorigenesis. The results were correlated with histoprognostic factors including Ki-67 index, presence of a fibrotic focus, and microvascular density (MVD).
Results: The cytoplasmic and nuclear expressions of the three PHD isoforms were associated, and their expression was significantly higher in aggressive PETS, malignant, with lymph node metastases or with lower MVD. High nuclear expression of the three isoforms highly correlated with HIF-1alpha nuclear expression (P = 0.02, 0.003, and 0.006, respectively). Moreover, high nuclear PHD-1 or PHD-3 expression was associated with a poorer survival (P = 0.01). Cytoplasmic FIH was significantly higher in malignant PETs (P = 0.05) and in PETs with lymph node metastases (P = 0.02), and its expression correlated positively with those of cytoplasmic PHD isoforms (P < 0001). FIH stromal expression was found in 23% of PETs and correlated with higher FIH nuclear expression (P = 0.0004) and poorer disease-free survival (P = 0.0018).
Conclusion: HIF regulatory proteins are highly expressed in PET and their expression is correlated with tumor metastases, tumor recurrence, and prognosis. These molecules that play an important role in the control of hypoxia-induced genes may have a function in the regulation of cellular proliferation and differentiation during endocrine tumorigenesis.
Similar articles
- Use of novel monoclonal antibodies to determine the expression and distribution of the hypoxia regulatory factors PHD-1, PHD-2, PHD-3 and FIH in normal and neoplastic human tissues.
Soilleux EJ, Turley H, Tian YM, Pugh CW, Gatter KC, Harris AL. Soilleux EJ, et al. Histopathology. 2005 Dec;47(6):602-10. doi: 10.1111/j.1365-2559.2005.02280.x. Histopathology. 2005. PMID: 16324198 - Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors.
Henze AT, Riedel J, Diem T, Wenner J, Flamme I, Pouyseggur J, Plate KH, Acker T. Henze AT, et al. Cancer Res. 2010 Jan 1;70(1):357-66. doi: 10.1158/0008-5472.CAN-09-1876. Epub 2009 Dec 22. Cancer Res. 2010. PMID: 20028863 - Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.
Jokilehto T, Rantanen K, Luukkaa M, Heikkinen P, Grenman R, Minn H, Kronqvist P, Jaakkola PM. Jokilehto T, et al. Clin Cancer Res. 2006 Feb 15;12(4):1080-7. doi: 10.1158/1078-0432.CCR-05-2022. Clin Cancer Res. 2006. PMID: 16489060 - Prolyl hydroxylase and hypoxia inducible factor: potential targets for cancer therapy.
Prabhu V, Guruvayoorappan C. Prabhu V, et al. Immunopharmacol Immunotoxicol. 2011 Sep;33(3):568-75. doi: 10.3109/08923973.2010.545418. Epub 2011 Jan 12. Immunopharmacol Immunotoxicol. 2011. PMID: 21226555 Review. - The prolyl hydroxylase enzymes that act as oxygen sensors regulating destruction of hypoxia-inducible factor alpha.
Willam C, Nicholls LG, Ratcliffe PJ, Pugh CW, Maxwell PH. Willam C, et al. Adv Enzyme Regul. 2004;44:75-92. doi: 10.1016/j.advenzreg.2003.11.017. Adv Enzyme Regul. 2004. PMID: 15581484 Review. No abstract available.
Cited by
- Nuclear-cytoplasmatic shuttling of proteins in control of cellular oxygen sensing.
Depping R, Jelkmann W, Kosyna FK. Depping R, et al. J Mol Med (Berl). 2015 Jun;93(6):599-608. doi: 10.1007/s00109-015-1276-0. Epub 2015 Mar 27. J Mol Med (Berl). 2015. PMID: 25809665 Review. - Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance.
Shi M, Yu DH, Chen Y, Zhao CY, Zhang J, Liu QH, Ni CR, Zhu MH. Shi M, et al. World J Gastroenterol. 2012 Feb 28;18(8):840-6. doi: 10.3748/wjg.v18.i8.840. World J Gastroenterol. 2012. PMID: 22371645 Free PMC article. - Decreased expression of prolyl hydroxylase 1 is associated with poor prognosis in colorectal cancers.
Melling N, Grass J, Reeh M, Tachezy M, Blessmann M, Izbicki JR, Grupp K. Melling N, et al. J Cancer Res Clin Oncol. 2023 Aug;149(10):7579-7585. doi: 10.1007/s00432-023-04717-y. Epub 2023 Mar 28. J Cancer Res Clin Oncol. 2023. PMID: 36976352 Free PMC article. - Sunitinib in pancreatic neuroendocrine tumors.
Raymond E, Hammel P, Dreyer C, Maatescu C, Hentic O, Ruszniewski P, Faivre S. Raymond E, et al. Target Oncol. 2012 Jun;7(2):117-25. doi: 10.1007/s11523-012-0220-2. Epub 2012 Jun 2. Target Oncol. 2012. PMID: 22661319 Review. - Current understanding of the molecular biology of pancreatic neuroendocrine tumors.
Zhang J, Francois R, Iyer R, Seshadri M, Zajac-Kaye M, Hochwald SN. Zhang J, et al. J Natl Cancer Inst. 2013 Jul 17;105(14):1005-17. doi: 10.1093/jnci/djt135. Epub 2013 Jul 9. J Natl Cancer Inst. 2013. PMID: 23840053 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical